Results from a trial of an mRNA vaccine for pancreatic cancer have shown that the vaccine reduces the chance of the cancer recurring in patients who initially respond.

Clinical studies indicate that the mRNA vaccine may help treat pancreatic cancer, one of the deadliest cancers, reports "Nature." This type of cancer ranks among the most lethal, and an effective treatment has yet to be found.

There is new hope in the fight against pancreatic cancer after early trials showed that personalized mRNA vaccines can target and reduce malignant tumors. NBC News medical contributor Dr. Kavita Patel reports on the vaccine’s success against pancreatic cancer,

"It's really exciting, because when we talk about curing cancer, it's not really a single monolithic disease," he added. "There are probably hundreds of different targets for ever

Clinical studies suggest that the mRNA vaccine may play a role in treating pancreatic cancer, identified as one of the most lethal cancers, according to a report in "Nature." Pancreatic cancer is among the deadliest,